Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

I can’t argue or disagree with your assessment.

Still a fair amount of uncertainty - although things do seem positive at the moment and into the near future.

Usually the Annual Meeting is a non-event but who knows w a new BOD chair and CEO in place and it would be a good place to

announce a CMO one of these days

Not expecting any new news coming out of the oral presentation at MASCC conference at the end of the month since they just had an abstract at ASCO and it’s been less than 2 months since the last patient was dosed in the RECOVER trial but as I like to say ‘Never say never’.
Regarding

I don't think it'd be unreasonable for the stock to hit $23 this summer.

I agree w that and it may be unreasonable to expect the stock to hit $30 this summer but I can see that happening under the right circumstances.
Regarding

I remember how badly I got burned when Fusilev didn't pan out as expected.

Yeah, I remember that too. Could it happen w pozi? Sure, Very preliminary data in Sept gave us a 73% response rate and in April it went down to 64% (which is still great) and if it goes down to 40% we’ll have a big winner but until we find out it’s not going to be 20% (which still beats SoC) we won’t know for sure of the trajectory SPPIs SP will take. In a sense this is so much different than the Fusilev fiasco where demand for Fusilev turned out to be a temporary thing. Actually I’m slightly wrong there. As I recall, after the initial fiasco, Fusilev sales were above 30M quarterly, in large part to the twice yearly price hikes they were implementing, till the generics came on the market. Whereas posi will be addressing an unmet need w no other drugs out there that can help. So when I say it could reach $30 this summer prior to WCLC news depends on whether investors figure out there is, in all likelyhood, no way pozi is going to get a 20% RR and it will be more like 40 or 50%. When investors figure that out or commit to that thought is when the SP will rise way north of $23.